ACADIA Pharmaceuticals Inc (ACAD)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
DSO (Days Sales Outstanding) is a vital metric used to evaluate the efficiency of a company's accounts receivable management. In the case of ACADIA Pharmaceuticals Inc, the provided data indicates that DSO information is missing for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. Without this specific data, we are unable to assess the average number of days it takes for ACADIA Pharmaceuticals Inc to collect revenue from its sales. Tracking DSO over time can provide insights into the company's credit policies, collection procedures, and overall liquidity. The absence of this information for the mentioned years limits our ability to make a thorough analysis of ACADIA Pharmaceuticals Inc's accounts receivable efficiency.
Peer comparison
Dec 31, 2024